Antimüllerian hormone in relation to tobacco and marijuana use and sources of indoor heating cooking

Wednesday, May 18, 2016

Authors:
Alexandra J. White, Ph.D., Dale P.…

Read More

Diminished ovarian reserve Is it a neglected cause in the assessment of recurrent miscarriage A cohort study

Sunday, May 1, 2016
Diminished ovarian reserve may be a hidden cause for recurrent miscarriage regardless of maternal age.

Read More

Antimüllerian hormone and pregnancy loss from the Effects of Aspirin in Gestation and Reproduction trial

Friday, April 1, 2016
Lower and higher antimullerian hormone levels are not associated with human chorionic gonadotropin- detected or clinical pregnancy loss in unassisted conceptions in women with a history of pregnancy loss.

Read More

Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth

Thursday, July 30, 2015
Personalized prediction of live-birth prognosis incorporating baseline clinical characteristics and antimullerian hormone can be achieved at a center specific level, with no added value from incorporating antral follicle count.

Read More

Comparison of markers of ovarian reserve between patients with complete mullerian agenesis and age matched fertile and infertile controls

Monday, June 29, 2015
This study investigated ovarian reserve in complete mullerian agenesis (CMA) patients and compared the ovarian reserve of CMA patients with age-matched fertile and infertile controls.

Read More

Role of ovarian reserve markers antimüllerian hormone and antral follicle count as aneuploidy markers in ongoing pregnancies and miscarriages

Wednesday, April 29, 2015
Antral follicle count appears to reflect the risk of autosomal trisomy better than maternal age. In contrast, antimullerian hormone does not deviate from the expected maternal age levels.

Read More

Antimullerian hormone levels decrease in female to male transsexual women using testosterone as cross sex therapy

Wednesday, April 29, 2015
Polycystic ovary syndrome is associated with elevated antimullerian hormone (AMH) levels. In this study, AMH serum levels significantly decreased after androgenic treatment in female-to-male transsexual subjects.

Read More

Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good prognosis patients at individual fertility clinics in two multicenter trials

Monday, March 30, 2015
Antimullerian hormone was a stronger predictor of ovarian response to controlled ovarian stimulation than AFC in both GnRH agonist and antagonist cycles, also when data were evaluated at the study center level.

Read More

Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool

Monday, March 30, 2015
An automated antimullerian hormone assay showed good correlations with age and antral follicle count and is a reproducible measure of the growing follicle pool.

Read More

Modification of the Beckman Coulter second generation enzyme linked immunosorbent assay protocol improves the reliability of serum antimüllerian hormone measurement

Friday, January 30, 2015
The modified second-generation enzyme-linked immunosorbent assay protocol eliminates potential intrinsic and extrinsic interference and gives more reliable results on sample dilution and storage compared with the original second-generation protocol.

Read More

Ovarian response to recombinant human follicle stimulating hormone A randomized antiMüllerian hormone stratified dose response trial in women undergoing in vitro fertilization intracytoplasmic sperm injection

Tuesday, November 25, 2014
Increasing rhFSH doses results in a linear increase in number of oocytes retrieved in an AMH-dependent manner.

Read More

Antimüllerian hormone regulates stem cell factor expression in human granulosa cells

Tuesday, November 25, 2014
Antimullerian hormone regulates stem cell factor via the cyclic adenosine 30:50 monophosphate/protein kinase A (cAMP/PKA) pathway in human granulosa cells.

Read More

BRCA1 germline mutations may be associated with reduced ovarian reserve

Tuesday, November 25, 2014
BRCA1 carriers have a decreased ovarian reserve, as evidenced by lower age- and body mass index–adjusted serum anti-Mullerian hormone levels, compared with women without BRCA mutations.

Read More

Effect of detorsion alone and in combination with enoxaparin therapy on ovarian reserve and serum antimüllerian hormone levels in a rat ovarian torsion model

Monday, June 2, 2014
Experimental study was designed to investigate the effect of enoxaparin treatment combination with ovarian detorsion on ovarian reserve and we found this therapy is more effective than detorsion alone treatment.

Read More

Antimullerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception

Thursday, May 15, 2014
Antimullerian hormone (AMH) and antral follicle count (AFC) are significantly lower among women with recent exposure to hormonal contraception. AMH and AFC should be interpreted cautiously when measured in the setting of recent hormone use.

Read More

Value of antimüllerian hormone as a prognostic indicator of in vitro fertilization outcome

Monday, March 31, 2014
Antimüllerian hormone is highly correlated with number of eggs retrieved. Very low levels are associated with diminished yet reasonable pregnancy rates, mediated through number of oocytes retrieved as opposed to oocyte quality.

Read More

Antimullerian hormone as a measure of reproductive function in female childhood cancer survivors

Tuesday, December 31, 2013
Antimullerian hormone may be the optimal screening tool for assessing ovarian reserve in childhood cancer survivors, allowing for timely initiation of pubertal induction and fertility counseling.

Read More

Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups An individual patient data meta analysis

Wednesday, July 31, 2013
This IPD meta-analysis demonstrates that AFC and AMH add value to age in predicting excessive response to ovarian hyperstimulation and that the accuracy of some ovarian reserve tests is affected by age.

Read More

Antimüllerian hormone in gonadotropin releasing hormone antagonist cycles Prediction of ovarian response and cumulative treatment outcome in good prognosis patients

Saturday, March 30, 2013
AMH predicts oocyte yield and poor and excessive ovarian response in GnRH antagonist cycles and is associated with increased cumulative live-birth rates after single-blastocyst transfer in fresh and cryopreserved cycles.

Read More

Biomarkers of ovarian response Current and future applications

Monday, March 18, 2013
Assessment of current strengths and limitations of antimullerian hormone and antral follicle count as ovarian biomarkers for assisted reproduction and evaluation of their future clinical applications by other health-care providers.

Read More

A common Asn680Ser polymorphism in the follicle stimulating hormone receptor gene is not associated with ovarian response to gonadotrophin stimulation in patients undergoing IVF

Wednesday, January 2, 2013
No association was demonstrated between follicle-stimulating hormone receptor gene variants and ovarian response in women undergoing in vitro fertilization treatment, but clinically relevant differences cannot be ruled out.

Read More

Predicting fertility with antimullerian hormone Is a cutoff value adequate

Thursday, November 29, 2012
Reflections on "Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study" by Hagen et al.

Read More

Translate »